Nrx pharmaceuticals, inc. (nasdaq:nrxp) and hope therapeutics, inc. announce participation at the h.c. wainwright 26th annual global investment conference september 9-11, 2024

Miami , sept. 3, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), a clinical-stage biopharmaceutical company, ("nrx," the "company") and hope therapeutics, inc., a medical and technology driven company and wholly-owned subsidiary of nrx, today announced they will be featured as a presenting companies at the h.c.
NRXP Ratings Summary
NRXP Quant Ranking